Diagnosis and management of cystic pancreatic lesions

Dushyant V. Sahani, Avinash Kambadakone, Michael MacAri, Noaki Takahashi, Suresh T Chari, Carlos Fernandez-Del Castillo

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this review is to outline the management guidelines for the care of patients with cystic pancreatic lesions. CONCLUSION. The guidelines are as follows: Annual imaging surveillance is generally sufficient for benign serous cystadenomas smaller than 4 cm and for asymptomatic lesions. Asymptomatic thin-walled unilocular cystic lesions smaller than 3 cm or side-branch intraductal papillary mucinous neoplasms should be followed up with CT or MRI at 6 and 12 months interval after detection. Cystic lesions with more complex features or with growth rates greater than 1 cm/year should be followed more closely or recommended for resection if the patient's condition allows surgery. Symptomatic cystic lesions, neoplasms with high malignant potential, and lesions larger than 3 cm should be referred for surgical evaluation. Endoscopic ultrasound with fine-needle aspiration (FNA) biopsy can be used preoperatively to assess the risk of malignancy.

Original languageEnglish (US)
Pages (from-to)343-354
Number of pages12
JournalAmerican Journal of Roentgenology
Volume200
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Serous Cystadenoma
Patient Care Management
Guidelines
Neoplasms
Fine Needle Biopsy
Growth

Keywords

  • Cystic pancreatic lesion
  • MDCT
  • MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Sahani, D. V., Kambadakone, A., MacAri, M., Takahashi, N., Chari, S. T., & Fernandez-Del Castillo, C. (2013). Diagnosis and management of cystic pancreatic lesions. American Journal of Roentgenology, 200(2), 343-354. https://doi.org/10.2214/AJR.12.8862

Diagnosis and management of cystic pancreatic lesions. / Sahani, Dushyant V.; Kambadakone, Avinash; MacAri, Michael; Takahashi, Noaki; Chari, Suresh T; Fernandez-Del Castillo, Carlos.

In: American Journal of Roentgenology, Vol. 200, No. 2, 02.2013, p. 343-354.

Research output: Contribution to journalArticle

Sahani, DV, Kambadakone, A, MacAri, M, Takahashi, N, Chari, ST & Fernandez-Del Castillo, C 2013, 'Diagnosis and management of cystic pancreatic lesions', American Journal of Roentgenology, vol. 200, no. 2, pp. 343-354. https://doi.org/10.2214/AJR.12.8862
Sahani DV, Kambadakone A, MacAri M, Takahashi N, Chari ST, Fernandez-Del Castillo C. Diagnosis and management of cystic pancreatic lesions. American Journal of Roentgenology. 2013 Feb;200(2):343-354. https://doi.org/10.2214/AJR.12.8862
Sahani, Dushyant V. ; Kambadakone, Avinash ; MacAri, Michael ; Takahashi, Noaki ; Chari, Suresh T ; Fernandez-Del Castillo, Carlos. / Diagnosis and management of cystic pancreatic lesions. In: American Journal of Roentgenology. 2013 ; Vol. 200, No. 2. pp. 343-354.
@article{13336f03029d42ea9b10f59057d0f9f5,
title = "Diagnosis and management of cystic pancreatic lesions",
abstract = "OBJECTIVE. The purpose of this review is to outline the management guidelines for the care of patients with cystic pancreatic lesions. CONCLUSION. The guidelines are as follows: Annual imaging surveillance is generally sufficient for benign serous cystadenomas smaller than 4 cm and for asymptomatic lesions. Asymptomatic thin-walled unilocular cystic lesions smaller than 3 cm or side-branch intraductal papillary mucinous neoplasms should be followed up with CT or MRI at 6 and 12 months interval after detection. Cystic lesions with more complex features or with growth rates greater than 1 cm/year should be followed more closely or recommended for resection if the patient's condition allows surgery. Symptomatic cystic lesions, neoplasms with high malignant potential, and lesions larger than 3 cm should be referred for surgical evaluation. Endoscopic ultrasound with fine-needle aspiration (FNA) biopsy can be used preoperatively to assess the risk of malignancy.",
keywords = "Cystic pancreatic lesion, MDCT, MRI",
author = "Sahani, {Dushyant V.} and Avinash Kambadakone and Michael MacAri and Noaki Takahashi and Chari, {Suresh T} and {Fernandez-Del Castillo}, Carlos",
year = "2013",
month = "2",
doi = "10.2214/AJR.12.8862",
language = "English (US)",
volume = "200",
pages = "343--354",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "2",

}

TY - JOUR

T1 - Diagnosis and management of cystic pancreatic lesions

AU - Sahani, Dushyant V.

AU - Kambadakone, Avinash

AU - MacAri, Michael

AU - Takahashi, Noaki

AU - Chari, Suresh T

AU - Fernandez-Del Castillo, Carlos

PY - 2013/2

Y1 - 2013/2

N2 - OBJECTIVE. The purpose of this review is to outline the management guidelines for the care of patients with cystic pancreatic lesions. CONCLUSION. The guidelines are as follows: Annual imaging surveillance is generally sufficient for benign serous cystadenomas smaller than 4 cm and for asymptomatic lesions. Asymptomatic thin-walled unilocular cystic lesions smaller than 3 cm or side-branch intraductal papillary mucinous neoplasms should be followed up with CT or MRI at 6 and 12 months interval after detection. Cystic lesions with more complex features or with growth rates greater than 1 cm/year should be followed more closely or recommended for resection if the patient's condition allows surgery. Symptomatic cystic lesions, neoplasms with high malignant potential, and lesions larger than 3 cm should be referred for surgical evaluation. Endoscopic ultrasound with fine-needle aspiration (FNA) biopsy can be used preoperatively to assess the risk of malignancy.

AB - OBJECTIVE. The purpose of this review is to outline the management guidelines for the care of patients with cystic pancreatic lesions. CONCLUSION. The guidelines are as follows: Annual imaging surveillance is generally sufficient for benign serous cystadenomas smaller than 4 cm and for asymptomatic lesions. Asymptomatic thin-walled unilocular cystic lesions smaller than 3 cm or side-branch intraductal papillary mucinous neoplasms should be followed up with CT or MRI at 6 and 12 months interval after detection. Cystic lesions with more complex features or with growth rates greater than 1 cm/year should be followed more closely or recommended for resection if the patient's condition allows surgery. Symptomatic cystic lesions, neoplasms with high malignant potential, and lesions larger than 3 cm should be referred for surgical evaluation. Endoscopic ultrasound with fine-needle aspiration (FNA) biopsy can be used preoperatively to assess the risk of malignancy.

KW - Cystic pancreatic lesion

KW - MDCT

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=84873583498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873583498&partnerID=8YFLogxK

U2 - 10.2214/AJR.12.8862

DO - 10.2214/AJR.12.8862

M3 - Article

C2 - 23345356

AN - SCOPUS:84873583498

VL - 200

SP - 343

EP - 354

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 2

ER -